Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin

Journal of Pineal Research
Thomas K H ChangEugene Y H Yeung

Abstract

Administration of melatonin to rodents decreases the incidence of tumorigenesis initiated by benzo[a]pyrene or 7,12-dimethylbenz[a]anthracene, which requires bioactivation by cytochrome P450 enzymes, such as CYP1A1, CYP1A2 and CYP1B1, to produce carcinogenic metabolites. The present study tested the hypothesis that melatonin is a modulator of human CYP1 catalytic activity and gene expression. As a comparison, we also investigated the effect of melatonin on the catalytic activity of CYP2A6, which is also a procarcinogen-bioactivating enzyme. Melatonin (3-300 microm) decreased 7-ethoxyresorufin O-dealkylation catalyzed by human hepatic microsomes and recombinant CYP1A1, CYP1A2 and CYP1B1, whereas it did not affect coumarin 7-hydroxylation catalyzed by hepatic microsomes or recombinant CYP2A6. Melatonin inhibited CYP1 enzymes by mixed inhibition, with apparent K(i) values (mean +/- S.E.M.) of 59 +/- 1 (CYP1A1), 12 +/- 1 (CYP1A2), 14 +/- 2 (CYP1B1) and 46 +/- 8 microm (hepatic microsomes). Additional experiments indicated that melatonin decreased benzo[a]pyrene hydroxylation catalyzed by hepatic microsomes and CYP1A2 but not by CYP1A1 or CYP1B1. Treatment of MCF-10A human mammary epithelial cells with melatonin (up to 300 microm) d...Continue Reading

References

Oct 1, 1984·Neuroendocrinology·F WaldhauserR J Wurtman
Jan 16, 1997·The New England Journal of Medicine·A Brzezinski
Jun 1, 1997·Environmental Health Perspectives·G D StonerG J Kelloff
Jun 24, 1998·Chemical Research in Toxicology·S S Hecht
May 8, 1999·Journal of Pineal Research·K YeleswaramK Santone
Dec 2, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·J E Lee, S Safe
Apr 25, 2001·European Journal of Clinical Pharmacology·G FaccioláG Tybring
Nov 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rae YuanShiew-Mei Huang
Jan 10, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Thomas K H ChangStelvio M Bandiera
Jan 24, 2003·Annual Review of Pharmacology and Toxicology·Michael S Denison, Scott R Nagy
Apr 3, 2003·Biochemical and Biophysical Research Communications·Dieter Schwarz, Ivar Roots
May 3, 2003·Life Sciences·Guofang ChenYukui Zhang
Nov 26, 2003·Biochemical Pharmacology·Barbara C SpinkDavid C Spink
Jun 23, 2004·Advances in Experimental Medicine and Biology·Ram K SindhuYutaka Kikkawa
Dec 8, 2004·Current Topics in Medicinal Chemistry·Costas Ioannides, David F V Lewis
Dec 14, 2004·Frontiers in Neuroendocrinology·M Mila Macchi, Jeffrey N Bruce
Dec 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xiaochao MaFrank J Gonzalez
Jan 22, 2005·Nature Reviews. Cancer·Andreas Luch
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Donghak Kim, F Peter Guengerich
Apr 13, 2005·European Journal of Clinical Pharmacology·Carina UrsingSven Röjdmark
Aug 5, 2005·International Journal of Cancer. Journal International Du Cancer·Samuel CosEmilio J Sánchez-Barceló
Mar 4, 2006·The Journal of Biological Chemistry·Yong-Heng ChenMichael R Stallcup
Mar 25, 2006·Future Oncology·Morag C E McFadyen, Graeme I Murray
Dec 7, 2007·Chemical Research in Toxicology·F Peter Guengerich
Feb 27, 2008·Journal of Pineal Research·A GonzalezE J Sanchez-Barcelo
Jun 11, 2008·Critical Reviews in Eukaryotic Gene Expression·Timothy V BeischlagGary H Perdew
Jun 11, 2008·Critical Reviews in Oncogenesis·Russel J ReiterLucien C Manchester
Jul 2, 2008·Breast Cancer Research and Treatment·Ahmet KorkmazRussel J Reiter
Aug 23, 2008·Journal of Pineal Research·Igor SemakAndrzej Slominski
Nov 18, 2008·Molecular Medicine·Ahmet KorkmazDun-Xian Tan
Nov 27, 2008·Journal of Experimental Botany·Sergio D ParedesRussel J Reiter
Feb 28, 2009·Nature Reviews. Drug Discovery·William N WilliamScott M Lippman

❮ Previous
Next ❯

Citations

Feb 27, 2013·Biochemical Pharmacology·George AndersonGianluigi Mazzoccoli
Mar 27, 2012·Chemical Research in Toxicology·Jiawang LiuMaryam Foroozesh
Nov 30, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jiawang LiuMaryam Foroozesh
Feb 5, 2013·Archives of Biochemistry and Biophysics·Wenchao ZhengColin R Jefcoate
May 19, 2004·Biochemical and Biophysical Research Communications·Cédric GaudineauKarine Auclair
May 6, 2008·The Journal of Steroid Biochemistry and Molecular Biology·Sarah M MenseHari K Bhat
Mar 23, 2017·Pharmacology & Therapeutics·Fei LiFrank J Gonzalez
May 2, 2017·European Journal of Medicinal Chemistry·Raphaël Dutour, Donald Poirier
Feb 11, 2021·International Journal of Molecular Sciences·George AndersonGianluigi Mazzoccoli
Jul 9, 2021·European Journal of Drug Metabolism and Pharmacokinetics·Sherif M ShoiebAyman O S El-Kadi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

World Journal of Gastroenterology : WJG
Chun-Qiu ChenMartin Storr
Clinica Chimica Acta; International Journal of Clinical Chemistry
Moli ChenXiaochang Liu
Toxicological Sciences : an Official Journal of the Society of Toxicology
Tom Simones, David M Shepherd
© 2022 Meta ULC. All rights reserved